Cytokines inhibit norepinephrine transporter expression by decreasing Hand2

Molecular and Cellular Neuroscience

Volumn 46, Issue 3, 2011, Pages 671-680

  Pellegrino, Michael J ^a   Parrish, Diana C ^a   Zigmond, Richard E ^b   Habecker, Beth A ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Axotomy; Cytokines; Gata3; Hand2; Phox2a; Sympathetic neurons

Indexed keywords

CYTOKINE; NORADRENALIN TRANSPORTER; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR GATA 3; TRANSCRIPTION FACTOR HAND2; TRANSCRIPTION FACTOR PHOX2A; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; GENE EXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; MOUSE; NERVE FIBER TRANSECTION; NEUROBLASTOMA CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SYMPATHETIC NERVE CELL; TRANSCRIPTION TERMINATION;

ANIMALS; AXOTOMY; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; CELLS, CULTURED; CILIARY NEUROTROPHIC FACTOR; CYTOKINES; GATA3 TRANSCRIPTION FACTOR; HOMEODOMAIN PROTEINS; HUMANS; MICE; NEURONS; NOREPINEPHRINE PLASMA MEMBRANE TRANSPORT PROTEINS; RATS; RATS, SPRAGUE-DAWLEY;

ANIMALIA;

EID: 79951853455     PISSN: 10447431     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mcn.2011.01.008     Document Type: Article

References (72)

1. Adachi M., Browne D., Lewis E.J. Paired-like homeodomain proteins Phox2a/Arix and Phox2b/NBPhox have similar genetic organization and independently regulate dopamine beta-hydroxylase gene transcription. DNA Cell Biol. 2000, 199:539-554.
2. Amara S.G., Kuhar M.J. Neurotransmitter transporters: recent progress. Annu. Rev. Neurosci. 1993, 16:73-93.
3. Apostolova G., Dechant G. Development of neurotransmitter phenotypes in sympathetic neurons. Auton. Neurosci. 2009, 1511:30-38.
4. Apostolova G., Loy B., Dorn R., Dechant G. The sympathetic neurotransmitter switch depends on the nuclear matrix protein satb2. J. Neurosci. 2010, 3048:16356-16364.
5. Brunet J.F., Pattyn A. Phox2 genes - from patterning to connectivity. Curr. Opin. Genet. Dev. 2002, 124:435-440.
6. Buss S.J., Backs J., Kreusser M.M., Hardt S.E., Maser-Gluth C., Katus H.A., Haass M. Spironolactone preserves cardiac norepinephrine reuptake in salt-sensitive Dahl rats. Endocrinology 2006, 1475:2526-2534.
7. Coppola E., Pattyn A., Guthrie S.C., Goridis C., Studer M. Reciprocal gene replacements reveal unique functions for Phox2 genes during neural differentiation. EMBO J. 2005, 2424:4392-4403.
8. Doxakis E., Howard L., Rohrer H., Davies A.M. HAND transcription factors are required for neonatal sympathetic neuron survival. EMBO Rep. 2008, 910:1041-1047.
9. Dziennis S., Habecker B.A. Cytokine suppression of dopamine-beta-hydroxylase by extracellular signal-regulated kinase-dependent and -independent pathways. J. Biol. Chem. 2003, 27818:15897-15904.
10. Dziennis S., Habecker B.A. Ciliary neurotrophic factor suppresses Phox2a in sympathetic neurons. NeuroReport 2004, 151:33-36.
11. Eisenhofer G., Friberg P., Rundqvist B., Quyyumi A.A., Lambert G., Kaye D.M., Kopin I.J., Goldstein D.S., Esler M.D. Cardiac sympathetic nerve function in congestive heart failure. Circulation 1996, 939:1667-1676.
12. Festa A., D'Agostino R., Howard G., Mykkanen L., Tracy R.P., Haffner S.M. Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS). Circulation 2000, 1021:42-47.
13. Gilsbach R., Faron-Gorecka A., Rogoz Z., Bruss M., Caron M.G., Dziedzicka-Wasylewska M., Bonisch H. Norepinephrine transporter knockout-induced up-regulation of brain alpha2A/C-adrenergic receptors. J. Neurochem. 2006, 964:1111-1120.
14. Goridis C., Rohrer H. Specification of catecholaminergic and serotonergic neurons. Nat. Rev. Neurosci. 2002, 37:531-541.
15. Habecker B.A., Sachs H.H., Rohrer H., Zigmond R.E. The dependence on gp130 cytokines of axotomy induced neuropeptide expression in adult sympathetic neurons. Dev. Neurobiol. 2009, 696:392-400.
16. Hawrot E., Patterson P.H. Long-term culture of dissociated sympathetic neurons. Meth. Enzymol. 1979, 58:574-584.
17. Hendershot T.J., Liu H., Sarkar A.A., Giovannucci D.R., Clouthier D.E., Abe M., Howard M.J. Expression of Hand2 is sufficient for neurogenesis and cell type-specific gene expression in the enteric nervous system. Dev. Dyn. 2007, 2361:93-105.
18. Hendershot T.J., Liu H., Clouthier D.E., Shepherd I.T., Coppola E., Studer M., Firulli A.B., Pittman D.L., Howard M.J. Conditional deletion of Hand2 reveals critical functions in neurogenesis and cell type-specific gene expression for development of neural crest-derived noradrenergic sympathetic ganglion neurons. Dev. Biol. 2008, 3192:179-191.
19. Hirsch M.R., Tiveron M.C., Guillemot F., Brunet J.F., Goridis C. Control of noradrenergic differentiation and Phox2a expression by MASH1 in the central and peripheral nervous system. Development 1998, 1254:599-608.
20. Holler K.L., Hendershot T.J., Troy S.E., Vincentz J.W., Firulli A.B., Howard M.J. Targeted deletion of Hand2 in cardiac neural crest-derived cells influences cardiac gene expression and outflow tract development. Dev. Biol. 2010, 3411:291-304.
21. Hong S.J., Huh Y., Chae H., Hong S., Lardaro T., Kim K.S. GATA-3 regulates the transcriptional activity of tyrosine hydroxylase by interacting with CREB. J. Neurochem. 2006, 983:773-781.
22. Hong S.J., Choi H.J., Hong S., Huh Y., Chae H., Kim K.S. Transcription factor GATA-3 regulates the transcriptional activity of dopamine beta-hydroxylase by interacting with Sp1 and AP4. Neurochem. Res. 2008, 339:1821-1831.
23. Hosoya T., Kuroha T., Moriguchi T., Cummings D., Maillard I., Lim K.C., Engel J.D. GATA-3 is required for early T lineage progenitor development. J. Exp. Med. 2009, 20613:2987-3000.
24. Howard M.J. Mechanisms and perspectives on differentiation of autonomic neurons. Dev. Biol. 2005, 2772:271-286.
25. Howard M.J., Stanke M., Schneider C., Wu X., Rohrer H. The transcription factor dHAND is a downstream effector of BMPs in sympathetic neuron specification. Development 2000, 12718:4073-4081.
26. Hsieh M.M., Lupas G., Rychlik J., Dziennis S., Habecker B.A., Lewis E.J. ERK1/2 is a negative regulator of homeodomain protein Arix/Phox2a. J. Neurochem. 2005, 946:1719-1727.
27. Kaaja R.J., Poyhonen-Alho M.K. Insulin resistance and sympathetic overactivity in women. J. Hypertens. 2006, 241:131-141.
28. Kanazawa H., Ieda M., Kimura K., Arai T., Kawaguchi-Manabe H., Matsuhashi T., Endo J., Sano M., Kawakami T., Kimura T., Monkawa T., Hayashi M., Iwanami A., Okano H., Okada Y., Ishibashi-Ueda H., Ogawa S., Fukuda K. Heart failure causes cholinergic transdifferentiation of cardiac sympathetic nerves via gp130-signaling cytokines in rodents. J. Clin. Invest. 2010, 1202:408-421.
29. Kim H.S., Seo H., Yang C., Brunet J.F., Kim K.S. Noradrenergic-specific transcription of the dopamine beta-hydroxylase gene requires synergy of multiple cis-acting elements including at least two Phox2a-binding sites. J. Neurosci. 1998, 1820:8247-8260.
30. Kim H.S., Yang C., Kim K.S. The cell-specific silencer region of the human dopamine beta-hydroxylase gene contains several negative regulatory elements. J. Neurochem. 1998, 711:41-50.
31. Kim C.H., Kim H.S., Cubells J.F., Kim K.S. A previously undescribed intron and extensive 5′ upstream sequence, but not Phox2a-mediated transactivation, are necessary for high level cell type-specific expression of the human norepinephrine transporter gene. J. Biol. Chem. 1999, 27410:6507-6518.
32. Kim C.H., Hwang D.Y., Park J.J., Kim K.S. A proximal promoter domain containing a homeodomain-binding core motif interacts with multiple transcription factors, including HoxA5 and Phox2 proteins, and critically regulates cell type-specific transcription of the human norepinephrine transporter gene. J. Neurosci. 2002, 227:2579-2589.
33. Kim C.H., Hahn M.K., Joung Y., Anderson S.L., Steele A.H., Mazei-Robinson M.S., Gizer I., Teicher M.H., Cohen B.M., Robertson D., Waldman I.D., Blakely R.D., Kim K.S. A polymorphism in the norepinephrine transporter gene alters promoter activity and is associated with attention-deficit hyperactivity disorder. Proc. Natl Acad. Sci. USA 2006, 10350:19164-19169.
34. Kreusser M.M., Buss S.J., Krebs J., Kinscherf R., Metz J., Katus H.A., Haass M., Backs J. Differential expression of cardiac neurotrophic factors and sympathetic nerve ending abnormalities within the failing heart. J. Mol. Cell. Cardiol. 2008, 442:380-387.
35. Landis S.C. Target regulation of neurotransmitter phenotype. Trends Neurosci. 1990, 138:344-350.
36. Li W., Knowlton D., Woodward W.R., Habecker B.A. Regulation of noradrenergic function by inflammatory cytokines and depolarization. J. Neurochem. 2003, 863:774-783.
37. Lillevali K., Matilainen T., Karis A., Salminen M. Partially overlapping expression of Gata2 and Gata3 during inner ear development. Dev. Dyn. 2004, 2314:775-781.
38. Lillevali K., Haugas M., Matilainen T., Pussinen C., Karis A., Salminen M. Gata3 is required for early morphogenesis and Fgf10 expression during otic development. Mech. Dev. 2006, 1236:415-429.
39. Lim K.C., Lakshmanan G., Crawford S.E., Gu Y., Grosveld F., Engel J.D. Gata3 loss leads to embryonic lethality due to noradrenaline deficiency of the sympathetic nervous system. Nat. Genet. 2000, 252:209-212.
40. Lo L., Tiveron M.C., Anderson D.J. MASH1 activates expression of the paired homeodomain transcription factor Phox2a, and couples pan-neuronal and subtype-specific components of autonomic neuronal identity. Development 1998, 1254:609-620.
41. Lo L., Morin X., Brunet J.F., Anderson D.J. Specification of neurotransmitter identity by Phox2 proteins in neural crest stem cells. Neuron 1999, 224:693-705.
42. Lucas M.E., Muller F., Rudiger R., Henion P.D., Rohrer H. The bHLH transcription factor hand2 is essential for noradrenergic differentiation of sympathetic neurons. Development 2006, 13320:4015-4024.
43. Maves L., Tyler A., Moens C.B., Tapscott S.J. Pbx acts with Hand2 in early myocardial differentiation. Dev. Biol. 2009, 3332:409-418.
44. Meyer J., Wiedemann P., Okladnova O., Bruss M., Staab T., Stober G., Riederer P., Bonisch H., Lesch K.P. Cloning and functional characterization of the human norepinephrine transporter gene promoter. J. Neural Transm. 1998, 10510-12:1341-1350.
45. Moriguchi T., Takako N., Hamada M., Maeda A., Fujioka Y., Kuroha T., Huber R.E., Hasegawa S.L., Rao A., Yamamoto M., Takahashi S., Lim K.C., Engel J.D. Gata3 participates in a complex transcriptional feedback network to regulate sympathoadrenal differentiation. Development 2006, 13319:3871-3881.
46. Morikawa Y., D'Autreaux F., Gershon M.D., Cserjesi P. Hand2 determines the noradrenergic phenotype in the mouse sympathetic nervous system. Dev. Biol. 2007, 3071:114-126.
47. Morin X., Cremer H., Hirsch M.R., Kapur R.P., Goridis C., Brunet J.F. Defects in sensory and autonomic ganglia and absence of locus coeruleus in mice deficient for the homeobox gene Phox2a. Neuron 1997, 183:411-423.
48. Pattyn A., Morin X., Cremer H., Goridis C., Brunet J.F. Expression and interactions of the two closely related homeobox genes Phox2a and Phox2b during neurogenesis. Development 1997, 12420:4065-4075.
49. Pattyn A., Morin X., Cremer H., Goridis C., Brunet J.F. The homeobox gene Phox2b is essential for the development of autonomic neural crest derivatives. Nature 1999, 3996734:366-370.
50. Pennica D., Shaw K.J., Swanson T.A., Moore M.W., Shelton D.L., Zioncheck K.A., Rosenthal A., Taga T., Paoni N.F., Wood W.I. Cardiotrophin-1. Biological activities and binding to the leukemia inhibitory factor receptor/gp130 signaling complex. J. Biol. Chem. 1995, 27018:10915-10922.
51. Potzner M.R., Tsarovina K., Binder E., Penzo-Mendez A., Lefebvre V., Rohrer H., Wegner M., Sock E. Sequential requirement of Sox4 and Sox11 during development of the sympathetic nervous system. Development 2010, 1375:775-784.
52. Raid R., Krinka D., Bakhoff L., Abdelwahid E., Jokinen E., Karner M., Malva M., Meier R., Pelliniemi L.J., Ploom M., Sizarov A., Pooga M., Karis A. Lack of Gata3 results in conotruncal heart anomalies in mouse. Mech. Dev. 2009, 1261-2:80-89.
53. Rao M.S., Landis S.C. Characterization of a target-derived neuronal cholinergic differentiation factor. Neuron 1990, 56:899-910.
54. Rao M.S., Sun Y., Escary J.L., Perreau J., Tresser S., Patterson P.H., Zigmond R.E., Brulet P., Landis S.C. Leukemia inhibitory factor mediates an injury response but not a target-directed developmental transmitter switch in sympathetic neurons. Neuron 1993, 116:1175-1185.
55. Rychlik J.L., Gerbasi V., Lewis E.J. The interaction between dHAND and Arix at the dopamine beta-hydroxylase promoter region is independent of direct dHAND binding to DNA. J. Biol. Chem. 2003, 27849:49652-49660.
56. Rychlik J.L., Hsieh M., Eiden L.E., Lewis E.J. Phox2 and dHAND transcription factors select shared and unique target genes in the noradrenergic cell type. J. Mol. Neurosci. 2005, 273:281-292.
57. Saadat S., Sendtner M., Rohrer H. Ciliary neurotrophic factor induces cholinergic differentiation of rat sympathetic neurons in culture. J. Cell Biol. 1989, 1085:1807-1816.
58. Sarkar A.A., Howard M.J. Perspectives on integration of cell extrinsic and cell intrinsic pathways of signaling required for differentiation of noradrenergic sympathetic ganglion neurons. Auton. Neurosci. 2006, 126-127:225-231.
59. Schimmel J.J., Crews L., Roffler-Tarlov S., Chikaraishi D.M. 4.5kb of the rat tyrosine hydroxylase 5′ flanking sequence directs tissue specific expression during development and contains consensus sites for multiple transcription factors. Brain Res. Mol. Brain Res. 1999, 741-2:1-14.
60. Schmidt M., Lin S., Pape M., Ernsberger U., Stanke M., Kobayashi K., Howard M.J., Rohrer H. The bHLH transcription factor Hand2 is essential for the maintenance of noradrenergic properties in differentiated sympathetic neurons. Dev. Biol. 2009, 3292:191-200.
61. Schotzinger R.J., Landis S.C. Cholinergic phenotype developed by noradrenergic sympathetic neurons after innervation of a novel cholinergic target in vivo. Nature 1988, 3356191:637-639.
62. Schotzinger R.J., Landis S.C. Acquisition of cholinergic and peptidergic properties by sympathetic innervation of rat sweat glands requires interaction with normal target. Neuron 1990, 51:91-100.
63. Stanke M., Duong C.V., Pape M., Geissen M., Burbach G., Deller T., Gascan H., Otto C., Parlato R., Schutz G., Rohrer H. Target-dependent specification of the neurotransmitter phenotype: cholinergic differentiation of sympathetic neurons is mediated in vivo by gp 130 signaling. Development 2006, 1331:141-150.
64. Sun Y., Zigmond R.E. Involvement of leukemia inhibitory factor in the increases in galanin and vasoactive intestinal peptide mRNA and the decreases in neuropeptide Y and tyrosine hydroxylase mRNA in sympathetic neurons after axotomy. J. Neurochem. 1996, 674:1751-1760.
65. Sun Y., Zigmond R.E. Leukaemia inhibitory factor induced in the sciatic nerve after axotomy is involved in the induction of galanin in sensory neurons. Eur. J. Neurosci. 1996, 810:2213-2220.
66. Tsarovina K., Pattyn A., Stubbusch J., Muller F., van der Wees J., Schneider C., Brunet J.F., Rohrer H. Essential role of Gata transcription factors in sympathetic neuron development. Development 2004, 13119:4775-4786.
67. Tsarovina K., Reiff T., Stubbusch J., Kurek D., Grosveld F.G., Parlato R., Schutz G., Rohrer H. The Gata3 transcription factor is required for the survival of embryonic and adult sympathetic neurons. J. Neurosci. 2010, 3032:10833-10843.
68. Valarche I., Tissier-Seta J.P., Hirsch M.R., Martinez S., Goridis C., Brunet J.F. The mouse homeodomain protein Phox2 regulates Ncam promoter activity in concert with Cux/CDP and is a putative determinant of neurotransmitter phenotype. Development 1993, 1193:881-896.
69. Wildner H., Gierl M.S., Strehle M., Pla P., Birchmeier C. Insm1 (IA-1) is a crucial component of the transcriptional network that controls differentiation of the sympatho-adrenal lineage. Development 2008, 1353:473-481.
70. Xu H., Firulli A.B., Zhang X., Howard M.J. HAND2 synergistically enhances transcription of dopamine-beta-hydroxylase in the presence of Phox2a. Dev. Biol. 2003, 2621:183-193.
71. Yamamori T., Fukada K., Aebersold R., Korsching S., Fann M.J., Patterson P.H. The cholinergic neuronal differentiation factor from heart cells is identical to leukemia inhibitory factor. Science 1989, 2464936:1412-1416.
72. Yang C., Kim H.S., Seo H., Kim C.H., Brunet J.F., Kim K.S. Paired-like homeodomain proteins, Phox2a and Phox2b, are responsible for noradrenergic cell-specific transcription of the dopamine beta-hydroxylase gene. J. Neurochem. 1998, 715:1813-1826.